227 related articles for article (PubMed ID: 24780874)
21. Acute severe radiation pneumonitis among non-small cell lung cancer (NSCLC) patients with moderate pulmonary dysfunction receiving definitive concurrent chemoradiotherapy: Impact of pre-treatment pulmonary function parameters.
Zhou Y; Yan T; Zhou X; Cao P; Luo C; Zhou L; Xu Y; Liu Y; Xue J; Wang J; Wang Y; Lu Y; Liang B; Gong Y
Strahlenther Onkol; 2020 Jun; 196(6):505-514. PubMed ID: 31828393
[TBL] [Abstract][Full Text] [Related]
22. The Plasma Levels and Polymorphisms of Vitronectin Predict Radiation Pneumonitis in Patients With Lung Cancer Receiving Thoracic Radiation Therapy.
Yu JH; Zhao QY; Liu Y; Zhu XR; Yang ZR; Fu XL; Cai XW
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):757-765. PubMed ID: 33610390
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer.
Hildebrandt MA; Komaki R; Liao Z; Gu J; Chang JY; Ye Y; Lu C; Stewart DJ; Minna JD; Roth JA; Lippman SM; Cox JD; Hong WK; Spitz MR; Wu X
PLoS One; 2010 Aug; 5(8):e12402. PubMed ID: 20811626
[TBL] [Abstract][Full Text] [Related]
24. A single-nucleotide polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene is associated with risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
Mak RH; Alexander BM; Asomaning K; Heist RS; Liu CY; Su L; Zhai R; Ancukiewicz M; Napolitano B; Niemierko A; Willers H; Choi NC; Christiani DC
Cancer; 2012 Jul; 118(14):3654-65. PubMed ID: 22144047
[TBL] [Abstract][Full Text] [Related]
25. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
Tang Y; Liu B; Li J; Wu H; Yang J; Zhou X; Yi M; Li Q; Yu S; Yuan X
Cancer Med; 2016 Jan; 5(1):24-32. PubMed ID: 26645682
[TBL] [Abstract][Full Text] [Related]
26. Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.
Wu X; Ye Y; Rosell R; Amos CI; Stewart DJ; Hildebrandt MA; Roth JA; Minna JD; Gu J; Lin J; Buch SC; Nukui T; Ramirez Serrano JL; Taron M; Cassidy A; Lu C; Chang JY; Lippman SM; Hong WK; Spitz MR; Romkes M; Yang P
J Natl Cancer Inst; 2011 May; 103(10):817-25. PubMed ID: 21483023
[TBL] [Abstract][Full Text] [Related]
27. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
[TBL] [Abstract][Full Text] [Related]
28. HSPB1 gene polymorphisms predict risk of mortality for US patients after radio(chemo)therapy for non-small cell lung cancer.
Xu T; Wei Q; Lopez Guerra JL; Wang LE; Liu Z; Gomez D; O'Reilly M; Lin SH; Zhuang Y; Levy LB; Mohan R; Zhou H; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e229-35. PubMed ID: 22608953
[TBL] [Abstract][Full Text] [Related]
29. Radiation Pneumonitis After Volumetric Modulated Arc Therapy for Non-small Cell Lung Cancer.
Fujiwara M; Doi H; Igeta M; Suzuki H; Kitajima K; Tanooka M; Ishida T; Wakayama T; Yokoi T; Kuribayashi K; Kijima T; Hashimoto M; Kondo N; Matsumoto S; Hasegawa S; Kamikonya N; Yamakado K
Anticancer Res; 2021 Nov; 41(11):5793-5802. PubMed ID: 34732453
[TBL] [Abstract][Full Text] [Related]
30. Patient-reported lung symptoms as an early signal of impending radiation pneumonitis in patients with non-small cell lung cancer treated with chemoradiation: an observational study.
Yue J; Shi Q; Xu T; Jeter M; Chen TY; Komaki R; Gomez DR; Pan T; Cleeland CS; Liao Z; Wang XS
Qual Life Res; 2018 Jun; 27(6):1563-1570. PubMed ID: 29549533
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
32. Impact of genetic variant of HIPK2 on the risk of severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
Tang Y; Yang L; Qin W; Yi MX; Liu B; Yuan X
Radiat Oncol; 2020 Jan; 15(1):9. PubMed ID: 31915028
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants in the ITGB6 gene is associated with the risk of radiation pneumonitis in lung cancer patients treated with thoracic radiation therapy.
Yi M; Tang Y; Liu B; Li Q; Zhou X; Yu S; Fu S; Cai Y; Yuan X
Tumour Biol; 2016 Mar; 37(3):3469-77. PubMed ID: 26449830
[TBL] [Abstract][Full Text] [Related]
34. Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.
Dang J; Li G; Zang S; Zhang S; Yao L
Radiat Oncol; 2014 Jul; 9():172. PubMed ID: 25074618
[TBL] [Abstract][Full Text] [Related]
35. Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.
Tsujino K; Hashimoto T; Shimada T; Yoden E; Fujii O; Ota Y; Satouchi M; Negoro S; Adachi S; Soejima T
J Thorac Oncol; 2014 Jul; 9(7):983-990. PubMed ID: 24922010
[TBL] [Abstract][Full Text] [Related]
36. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
Katsui K; Ogata T; Watanabe K; Katayama N; Kuroda M; Kiura K; Hiraki T; Maeda Y; Toyooka S; Kanazawa S
Cancer Med; 2020 Jul; 9(13):4540-4549. PubMed ID: 32364685
[TBL] [Abstract][Full Text] [Related]
37. Dose-volume analysis of radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent cisplatinum and etoposide with or without consolidation docetaxel.
Barriger RB; Fakiris AJ; Hanna N; Yu M; Mantravadi P; McGarry RC
Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1381-6. PubMed ID: 20231061
[TBL] [Abstract][Full Text] [Related]
38. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
39. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer.
Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G
PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103
[TBL] [Abstract][Full Text] [Related]
40. Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
Lopez Guerra JL; Gomez D; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1573-9. PubMed ID: 22768989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
